Navigating the GLP-1 Boom: Clinical Strategy and Industry Insights

2026 ASCO: Navigating the Era of Adoptive Cellular Therapy and Finite-Duration Regimens in Advanced Malignancies

A fundamental shift is underway in advanced oncology: the move from continuous, 'treat-to-progression' regimens to high-efficacy, finite-duration protocols. This evolution redefines long-term patient management and offers new potential for durable, treatment-free responses.

The Early-Onset Cancer Epidemic: A Clinical Briefing on Global Patterns, Biology, and Practice Paradigms

Early-onset cancers are rising globally among adults under 50, driving earlier screening, expanded genomic testing, fertility-focused care, and greater attention to lifestyle-related risk factors.

Bridging The Gap In Schizophrenia Care: Lessons From A National Analysis Of Medicaid Beneficiaries

A nationwide Medicaid analysis reveals persistent schizophrenia care gaps, with poor medication adherence driving high emergency and hospitalization rates, highlighting urgent needs for integrated, proactive care.

Daraxonrasib: Shifting the Paradigm in Metastatic Pancreatic Cancer

Daraxonrasib significantly improves survival, disease control, and quality of life in metastatic pancreatic cancer, marking a major advance in targeted second-line treatment options.

AI Tools May Enhance Lung Cancer Screening and Risk Prediction

AI-powered imaging tools are enhancing lung cancer risk assessment by identifying high-risk patients earlier, expanding screening opportunities, and supporting more equitable, personalized detection strategies.